New Key Statistics Module, Z-Score and F-Score
NAS:BNTC Key Ratios
Market Cap $ M | 82.30 |
Enterprise Value $ M | 71.34 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.93 |
Price/Sales | 2,032.77 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -9.69 |
Beneish M-Score | 1.8 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -3.29 |
EV-to-EBITDA | -3.34 |
PEG | -- |
Shares Outstanding M | 10.09 |
Net Margin (%) | -309,885.71 |
Operating Margin % | -307,028.57 |
Pre-tax Margin (%) | -309,885.71 |
Quick Ratio | 4.18 |
Current Ratio | 4.18 |
ROA % (ttm) | -142.54 |
ROE % (ttm) | -200.14 |
ROIC % (ttm) | -1,493.74 |
Dividend Yield % | -- |
Altman Z-Score | -6.56 |
BNTC Number of Guru Trades
BNTC Volume of Guru Trades
Gurus Latest Trades with NAS:BNTC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BNTC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Benitec Biopharma Inc Insider Transactions
No Available Data
News about NAS:BNTC
Total 0- 1